31958571 35903451 36498944 35639028 35052685 34829402 33096030 33464700 35469167 36306655 32505218 36232681 35788089 34890841 32392908 35213002 35250559 35777449 35218041 34923569 32312902 35094654 34233172 33400402 34887768 31694154 - Search Results

Year	Number of Results
2019	1
2020	5
2021	8
2022	14
2023	0

1

Novel signaling aspects of ceramide 1-phosphate.

Presa N, Gomez-Larrauri A, Dominguez-Herrera A, Trueba M, Gomez-Muñoz A. Presa N, et al. Biochim Biophys Acta Mol Cell Biol Lipids. 2020 Apr;1865(4):158630. doi: 10.1016/j.bbalip.2020.158630. Epub 2020 Jan 17. Biochim Biophys Acta Mol Cell Biol Lipids. 2020. PMID: 31958571 Review.

2

Coix Seed-Based Milk Fermented With Limosilactobacillus reuteri Improves Lipid Metabolism and Gut Microbiota in Mice Fed With a High-Fat Diet.

Yang Z, Zhu X, Wen A, Ran J, Qin L, Zhu Y. Yang Z, et al. Front Nutr. 2022 Jul 12;9:921255. doi: 10.3389/fnut.2022.921255. eCollection 2022. Front Nutr. 2022. PMID: 35903451 Free PMC article.

3

FTY720 Reduces Lipid Accumulation by Upregulating ABCA1 through Liver X Receptor and Sphingosine Kinase 2 Signaling in Macrophages.

Tachibana K, Kusumoto K, Ogawa M, Ando H, Shimizu T, Ishima Y, Ishida T, Okuhira K. Tachibana K, et al. Int J Mol Sci. 2022 Nov 23;23(23):14617. doi: 10.3390/ijms232314617. Int J Mol Sci. 2022. PMID: 36498944 Free PMC article.

4

A new preclinical model of western diet-induced progression of non-alcoholic steatohepatitis to hepatocellular carcinoma.

Green CD, Weigel C, Brown RDR, Bedossa P, Dozmorov M, Sanyal AJ, Spiegel S. Green CD, et al. FASEB J. 2022 Jul;36(7):e22372. doi: 10.1096/fj.202200346R. FASEB J. 2022. PMID: 35639028 Free PMC article.

5

Fatty Acid Synthase Inhibitor Platensimycin Intervenes the Development of Nonalcoholic Fatty Liver Disease in a Mouse Model.

Su M, Cao D, Wang Z, Duan Y, Huang Y. Su M, et al. Biomedicines. 2021 Dec 21;10(1):5. doi: 10.3390/biomedicines10010005. Biomedicines. 2021. PMID: 35052685 Free PMC article.

6

Involvement of Ceramides in Non-Alcoholic Fatty Liver Disease (NAFLD) Atherosclerosis (ATS) Development: Mechanisms and Therapeutic Targets.

Tanase DM, Gosav EM, Petrov D, Jucan AE, Lacatusu CM, Floria M, Tarniceriu CC, Costea CF, Ciocoiu M, Rezus C. Tanase DM, et al. Diagnostics (Basel). 2021 Nov 5;11(11):2053. doi: 10.3390/diagnostics11112053. Diagnostics (Basel). 2021. PMID: 34829402 Free PMC article. Review.

7

The apoM-S1P axis in hepatic diseases.

Chen Z, Hu M. Chen Z, et al. Clin Chim Acta. 2020 Dec;511:235-242. doi: 10.1016/j.cca.2020.10.023. Epub 2020 Oct 21. Clin Chim Acta. 2020. PMID: 33096030 Free article. Review.

8

Herp knockout protects against nonalcoholic fatty liver disease in mice on a high fat diet.

Lei ZX, Wang JJ, Li K, Liu P. Lei ZX, et al. Kaohsiung J Med Sci. 2021 Jun;37(6):487-496. doi: 10.1002/kjm2.12349. Epub 2021 Jan 19. Kaohsiung J Med Sci. 2021. PMID: 33464700 Free article.

9

Lipid alterations in chronic liver disease and liver cancer.

Paul B, Lewinska M, Andersen JB. Paul B, et al. JHEP Rep. 2022 Mar 26;4(6):100479. doi: 10.1016/j.jhepr.2022.100479. eCollection 2022 Jun. JHEP Rep. 2022. PMID: 35469167 Free PMC article. Review.

10

Establishment of a lipid metabolism disorder model in ApoEb mutant zebrafish.

Hu YX, You HM, Zhu RF, Liang YL, Li FF, Qin YW, Zhao XX, Liang C, Jing Q. Hu YX, et al. Atherosclerosis. 2022 Nov;361:18-29. doi: 10.1016/j.atherosclerosis.2022.10.008. Epub 2022 Oct 19. Atherosclerosis. 2022. PMID: 36306655

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results